SCHEMBL2543348

SCHEMBL2543348

CSCC[C@H](NC(=O)[C@@H](N)CS)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FNTA P49354 15/20 0.67
FNTB P49356 15/20 0.67
PGGT1B P53609 12/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27799999 1.00 FNTA (0.67) FNTAFNTBPGGT1B
SCHEMBL29359191 0.97 FNTA (0.64) FNTAFNTBPGGT1B
SCHEMBL30010209 0.93 FNTA (0.59) FNTAFNTBPGGT1B
SCHEMBL30011327 0.93 FNTA (0.59) FNTAFNTBPGGT1B
SCHEMBL30011004 0.93 FNTA (0.59) FNTAFNTBPGGT1B
SCHEMBL30011791 0.93 FNTA (0.59) FNTAFNTBPGGT1B
SCHEMBL13138431 0.91 FNTA (0.68) FNTAFNTBPGGT1B
SCHEMBL26818366 0.91 FNTA (0.68) FNTAFNTBPGGT1B
SCHEMBL29656454 0.89 FNTA (0.60) FNTAFNTBPGGT1B
SCHEMBL2312650 0.89 LMNA (0.57) FNTAFNTBPGGT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114945580-A Method for synthesizing Nanjibor peptide 北京费森尤斯卡比医药有限公司 2022-08-26 CN claimed
CN-101897691-A Application of isothiocyanate compounds in promoting hair growth WUXI JC PHARMACAUTICAL TECHNOLOGY INC 2010-12-01 CN claimed
US-20250380730-A1 PLANT ONLY UMAMI FLAVORING REPLACEMENT SYSTEM IN FOOD PRODUCTS THE LIVE GREEN GROUP INC (US) 2025-12-18 US disclosed
US-20250257095-A1 METHOD FOR VISIBLE LIGHT-MEDIATED CHEMICAL MODIFICATION OF POLYPEPTIDE AND PROTEIN BASED ON CYSTEINE SHANGHAI JIAO TONG UNIVERSITY (CN) 2025-08-14 US disclosed
EP-4545545-A1 VISIBLE LIGHT-MEDIATED CYSTEINE-BASED POLYPEPTIDE AND PROTEIN CHEMICAL MODIFICATION METHOD Shanghai Jiao Tong University (CN) 2025-04-30 EP disclosed
EP-4515229-A1 BIOSENSOR TESTING SYSTEM AND METHODS OF USE QUIDEL CORPORATION (US) 2025-03-05 EP disclosed
CN-118777592-A Colloidal gold test strip for detecting anti-PLA 2R antibody, preparation method thereof, kit and application 江南大学 2024-10-15 CN disclosed
EP-4370150-A1 OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS Intervet International B.V. (NL) 2024-05-22 EP disclosed
CN-117940585-A Methods for identifying responsiveness to fibroblast growth factor receptor 1 inhibitor therapy 科隆大学 2024-04-26 CN disclosed
WO-2024007714-A1 VISIBLE LIGHT-MEDIATED CYSTEINE-BASED POLYPEPTIDE AND PROTEIN CHEMICAL MODIFICATION METHOD 上海交通大学 2024-01-11 WO disclosed
WO-2024009272-A1 PLANT ONLY UMAMI FLAVORING REPLACEMENT SYSTEM IN FOOD PRODUCTS THE LIVE GREEN GROUP, INC., (US) 2024-01-11 WO disclosed
CN-101897691-B Application of isothiocyanate compounds in promoting hair growth WUXI JC PHARMACEUTICAL TECHNOLOGY INC 2013-06-05 CN disclosed
US-20130130317-A1 METHOD FOR PRODUCING SUBSTANCE KYOWA HAKKO KIRIN CO., LTD (JP) 2013-05-23 US disclosed
CN-102504022-A Proinsulin containing protecting lysine and preparation method for insulin by utilizing proinsulin SUZHOU YUANJI BIOLOG TECHNOLOGY CO LTD 2012-06-20 CN disclosed
US-20110262962-A1 METHOD FOR PRODUCING PEPTIDES AJINOMOTO CO., INC. (JP) 2011-10-27 US disclosed
CN-101897691-A Application of isothiocyanate compounds in promoting hair growth WUXI JC PHARMACAUTICAL TECHNOLOGY INC 2010-12-01 CN disclosed
US-20070292916-A1 MUTANT PROTEIN HAVING THE PEPTIDE-SYNTHESIZING ACTIVITY AJINOMOTO CO., INC. (JP) 2007-12-20 US disclosed
EP-1829968-A1 MUTANT PROTEIN HAVING PEPTIDE-PRODUCTION ACTIVITY Ajinomoto Co., Inc. (JP) 2007-09-05 EP disclosed
US-20070190602-A1 Mutant protein having the peptide-synthesizing activity AJINOMOTO CO., INC (JP) 2007-08-16 US disclosed
US-20060188976-A1 Mutant protein having the peptide-synthesizing activity AJINOMOTO CO. INC (JP) 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250257095-A1 METHOD FOR VISIBLE LIGHT-MEDIATED CHEMICAL MODIFICATION OF POLYPEPTIDE AND PROTEIN BASED ON CYSTEINE PTMS, CTH, CISD1 FNTA 897/4885FNTB 977/4885PGGT1B 4645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.